Sandi Motisi
Family · Libertyville, ILNPI 1821233149
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 808 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 48 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 808 payments — averaging $16.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$3K
- AbbVie$2K
- Amgen$1K
- AstraZeneca$800
- Lilly USA, LLC$791
- Takeda Pharmaceuticals U.S.A., Inc.$476
- plus $5K from 42 others
What the payments were for
- Food & beverage$13,278100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$13,278 in reported general payments places this provider in the 95th percentile of 4,941 family providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 27 | $46,033 |
| FarxigaDapagliflozin Propanediol | 15 | $21,174 |
| JardianceEmpagliflozin | 15 | $21,066 |
| MounjaroTirzepatide | 15 | $20,666 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $16,861 |
| SynthroidLevothyroxine Sodium | 31 | $2,049 |
| Celecoxib | 24 | $1,687 |
| Atorvastatin Calcium | 101 | $740 |
| Metoprolol Succinate | 34 | $672 |
| Escitalopram Oxalate | 33 | $641 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $584 |
| Pantoprazole Sodium | 34 | $491 |
| Fluticasone Propionate | 27 | $437 |
| Bupropion XlBupropion Hcl | 13 | $436 |
| FenofibrateFenofibrate Nanocrystallized | 12 | $434 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $2,644 | $46,03327 claims |
| AstraZenecaFarxiga | $800 | $21,17415 claims |
| Boehringer IngelheimJardiance | $281 | $21,06615 claims |
| Lilly USA, LLCMounjaro | $791 | $20,66615 claims |
| GSKTrelegy Ellipta | $256 | $16,86112 claims |
| AbbVieSynthroid | $2,199 | $2,04931 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,941 family providers in Illinois.
Other family in Libertyville
- Ruth CarricoChicago$578K
- Aleksandra BielawiecBarrington$373K
- Erin SieberNaperville$334K
- Jamie BroganChicago$282K
- Ashley NoethGlen Carbon$271K
- Marita KametasChicago$259K
- Shammona ClarkChicago$247K
- Amanda McKeeMount Vernon$242K
- Amy BrownellElk Grove Village$202K
- Brittony CroasdellChicago$192K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.